JH
Therapeutic Areas
Oragenics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ONP-002 | Concussion / mild Traumatic Brain Injury (mTBI) | Phase 2 |
| ONP-001 | Rare Leukodystrophies (e.g., Niemann-Pick Disease Type C) | Preclinical |
| NT-CoV-2 (Terra CoV-2) | Prevention of COVID-19 and SARS-CoV-2 variants | Preclinical |
| Lantibiotics Program | Infections from multidrug-resistant bacteria | Not Disclosed |